TTD | Drug: D0BH2T

Drug General Information
Drug ID	D0BH2T
Former ID	DNC013340
Drug Name	2,2',4,4'-tetrahydroxychalcone
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528649]
Structure		Download 2D MOL 3D MOL
Formula	C15H12O5
Canonical SMILES	C1=CC(=C(C=C1O)O)C=CC(=O)C2=C(C=C(C=C2)O)O
InChI	1S/C15H12O5/c16-10-3-1-9(14(19)7-10)2-6-13(18)12-5-4-11(17)8-15(12)20/h1-8,16-17,19-20H/b6-2+
InChIKey	ZWTDXYUDJYDHJR-QHHAFSJGSA-N
PubChem Compound ID	10107266
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[528649]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
PathWhiz Pathway	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 528649	Bioorg Med Chem. 2007 Mar 15;15(6):2396-402. Epub 2007 Jan 17.Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
Ref 528649	Bioorg Med Chem. 2007 Mar 15;15(6):2396-402. Epub 2007 Jan 17.Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information